Page 60 - HIV/AIDS Guidelines

130.Chen RY, Accortt NA, Westfall AO, et al. Distribution of health care expenditures for HIV-infected patients. Clin Infect
Dis. Apr 1 2006;42(7):1003-1010.
131.Willig JH, Abroms S, Westfall AO, et al. Increased regimen durability in the era of once-daily fixed-dose combination
antiretroviral therapy. AIDS. Oct 1 2008;22(15):1951-1960.
132.Bicanic T, Meintjes G, Rebe K, et al. Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal
meningitis: a prospective study. J Acquir Immune Defic Syndr. Jun 1 2009;51(2):130-134.
133.Phillips P, Bonner S, Gataric N, et al. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected
patients: spectrum of disease and long-term follow-up. Clin Infect Dis. Nov 15 2005;41(10):1483-1497.
134.Velasco M, Castilla V, Sanz J, et al. Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV
patients with tuberculosis. J Acquir Immune Defic Syndr. Feb 1 2009;50(2):148-152.
135.Abdool Karim SS, Naidoo K, Grobler A, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N
Engl J Med. Feb 25 2010;362(8):697-706.
136.Abdool Karim SS, Naidoo K, Grobler A, et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J
Med. Oct 20 2011;365(16):1492-1501.
137.Blanc FX, Sok T, Laureillard D, et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with
tuberculosis. N Engl J Med. Oct 20 2011;365(16):1471-1481.
138.Havlir DV, Kendall MA, Ive P, et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med.
Oct 20 2011;365(16):1482-1491.
139.Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic
infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV
Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. Apr 10 2009;58(RR-4):1-207.
140.Lu M, Safren SA, Skolnik PR, et al. Optimal recall period and response task for self-reported HIV medication adherence.
AIDS Behav. Jan 2008;12(1):86-94.
141.Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy
adherence: A review with recommendations for HIV research and clinical management. AIDS Behav. May
2006;10(3):227-245.
142.Bisson GP, Gross R, Bellamy S, et al. Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-
infected adults on antiretroviral therapy. PLoS Med. May 20 2008;5(5):e109.
143.Kalichman SC, Amaral CM, Cherry C, et al. Monitoring medication adherence by unannounced pill counts conducted by
telephone: reliability and criterion-related validity. HIV Clin Trials. Sep-Oct 2008;9(5):298-308.
144.Moss AR, Hahn JA, Perry S, et al. Adherence to highly active antiretroviral therapy in the homeless population in San
Francisco: a prospective study. Clin Infect Dis. Oct 15 2004;39(8):1190-1198.
145.Hunt PW, Brenchley J, Sinclair E, et al. Relationship between T cell activation and CD4+ T cell count in HIV-
seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis. Jan 1
2008;197(1):126-133.
146.Choudhary SK, Vrisekoop N, Jansen CA, et al. Low immune activation despite high levels of pathogenic human
immunodeficiency virus type 1 results in long-term asymptomatic disease. J Virol. Aug 2007;81(16):8838-8842.
147.Egger M. Outcomes of ART in resource-limited and industrialized countries. Paper presented at: 14th Conference on
Retroviruses and Opportunistic Infections (CROI): Feb. 25-28 2007; Los Angeles, CA.
148.Wolbers M, Bucher HC, Furrer H, et al. Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in
the Swiss HIV Cohort Study. HIV Med. Jul 2008;9(6):397-405.
149.Grigoryan A, Hall HI, Durant T, Wei X. Late HIV diagnosis and determinants of progression to AIDS or death after HIV
diagnosis among injection drug users, 33 US States, 1996-2004. PLoS One. 2009;4(2):e4445.

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents E-19

Downloaded from http://aidsinfo.nih.gov/guidelines on 12/8/2012 EST.